about
Fever therapy revisitedUse of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in miceA novel method to identify and characterise peptide mimotopes of heat shock protein 70-associated antigens.Tumor-specific shared antigenic peptides recognized by human T cells.Towards patient-specific tumor antigen selection for vaccination.The future of vaccination as a treatment strategy in dermatological diseases.Prospects for immunotherapy of malignant disease.Overview of the clinical efficacy of investigational anticancer drugs.Therapeutic vaccination for the treatment of mucosotropic human papillomavirus-associated disease.Tumor antigens and proteomics from the point of view of the major histocompatibility complex peptides.Antigen-specific immunotherapy and cancer vaccines.Phase III multicenter clinical trial of the sialyl-TN (STn)-keyhole limpet hemocyanin (KLH) vaccine for metastatic breast cancer.ALK a novel lymphoma-associated tumor antigen for vaccination strategies.Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer VaccinesInduction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination constructCytotoxic T-cell precursor frequencies to HER-2 (369-377) in patients with HER-2/neu-positive epithelial tumoursPD-L1 mediated the differentiation of tumor-infiltrating CD19(+) B lymphocytes and T cells in Invasive breast cancerDendritic cell vaccine strategies for renal cell carcinoma.The influence of different culture microenvironments on the generation of dendritic cells from non-small-cell lung cancer patients.Cancer vaccines. Any future?Immunotherapy of prostate cancer: should we be targeting stem cells and EMT?New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.Epigenetic regulation and molecular characterization of C/EBPalpha in pancreatic cancer cells.Immunotherapeutic approaches for cancer therapy: An updated review.A melanoma multiepitope polypeptide induces specific CD8+ T-cell response.mRNA Cancer Vaccines.Enhanced major histocompatibility complex class I binding and immune responses through anchor modification of the non-canonical tumour-associated mucin 1-8 peptide.Archaeosomes as self-adjuvanting delivery systems for cancer vaccines.Tumour cell contamination of autologous stem cells grafts in high-risk neuroblastoma: the good news?Design of enhanced agonists through the use of a new virtual screening method: application to peptides that bind class I major histocompatibility complex (MHC) molecules.New BAGE (B melanoma antigen) genes mapping to the juxtacentromeric regions of human chromosomes 13 and 21 have a cancer/testis expression profile.Ectopic expression of germline genes drives malignant brain tumor growth in Drosophila.
P2860
Q24650460-77C79B46-B13C-47D2-ACF2-5F9A9C083375Q24806827-89DD7EFC-845A-4B6B-8349-219A8BCDB789Q33239312-8AA33D37-CB49-4DB7-BC37-00A42E0BE5ADQ35005926-A5ADA22A-B3D4-4D44-81F9-84906AD658C3Q35005960-623AFCB3-1C18-4863-A672-B4F54D144360Q35015879-66072FEE-8CD0-4777-BB9F-A36A51513636Q35041705-513F5876-1065-4D4D-AEFE-410CA2A8EFBEQ35067125-DB258E0B-0E9F-46AA-B44D-C7216EDA1FF0Q35144042-5B92100A-4905-41E4-9DCA-D1104CB1C7E5Q35160569-A7C99416-5AB5-4395-9A01-1EA57654EEC8Q35199473-31FD10B5-9528-4F5E-81B3-FBC0D4F4C85FQ35584716-89976251-B0FC-4538-BA8C-6C00EA084143Q35614635-80303CC0-8DD9-426F-B5A6-78379791ECBCQ35774908-9F44678A-31C9-48E3-9B40-3673F818FDAAQ36616720-30A7E7D9-F9E8-4D14-B359-90C225D56544Q36648360-27CCE46D-67D0-4D7B-85AC-3659E4FF0804Q36711049-075A4E68-4B88-4784-A74D-3B92A294C0CCQ36717351-EF9EDB19-568F-4645-B848-B9375DA69E55Q37397746-8399289B-E43B-4DEB-A5C9-58E97DB623EEQ37885282-7F0082C4-3A65-4375-B261-C8878ABA66B7Q37891875-ABA0324A-CD79-46D2-803F-62324A7ECB6EQ38245928-76CC08C1-FCC0-40C2-90AB-A40E4B9DBC03Q38358635-91B5BD7A-F5C9-4210-9017-128403587CB9Q38388102-C4319396-F333-4659-AB6F-8973AD5B1129Q38845278-601010DF-9BA5-43C7-AC2C-BA8CB259042AQ39013357-2553310C-C1B1-46A8-8B87-CE77791B1A90Q40215247-1EBC9D92-8ECF-414D-985E-B1A25CB13A21Q40544057-78671437-495A-4570-BF7D-AE681D3D40F9Q41850915-958FE07A-29E1-4149-A023-A3783ED10E3BQ43093883-BC8E5521-CC5C-4A4B-8E74-7D268E9823E6Q48271052-733BFC2A-8698-4562-A12E-313D0D2067AFQ52713517-EFDBEFA8-E1CA-4DE7-AD10-0D04236EDBDF
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Clinical cancer vaccine trials.
@ast
Clinical cancer vaccine trials.
@en
Clinical cancer vaccine trials.
@nl
type
label
Clinical cancer vaccine trials.
@ast
Clinical cancer vaccine trials.
@en
Clinical cancer vaccine trials.
@nl
prefLabel
Clinical cancer vaccine trials.
@ast
Clinical cancer vaccine trials.
@en
Clinical cancer vaccine trials.
@nl
P2093
P1476
Clinical cancer vaccine trials.
@en
P2093
Alexander Knuth
Dirk Jäger
Elke Jäger
P304
P356
10.1016/S0952-7915(02)00318-7
P577
2002-04-01T00:00:00Z